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Abstract. Intake of trans fatty acids from hydrogenated fish oils
has been related to increased risk of coronary heart diseases.
The possible effect on colorectal carcinogenesis is unclear.
Materials and Methods: Multiple intestinal neoplasia (Min/+)
mice were fed one of four experimental diets: either raw fish oil
(FO), low (LHFO)-, high (HHFO)- or fully-hydrogenated fish
oil (FFHO), from 0 to 9 weeks of age. The number and size of
intestinal tumors were recorded. Results: There was no difference
between the intervention groups in the numbers of developed
intestinal tumors. The tumor size was statistically significantly
lower in HHFO vs. the FO-group in male Min/+ mice. The
HHFO and FHFO groups had lower weight gain than did the
FO group (p=0.008 and p=0.04, respectively), but gender
differences, due to effect of dietary intervention on weight gain,
were found in Min/+ mice. Conclusion: When compared with
raw fish oil, different degrees of hydrogenation of the fish oil had
no effect on intestinal carcinogenesis in Min/+ mice.
Partially hydrogenated oils rich in trans fatty acids are one of
the suspected dietary risk factors for colorectal cancer (CRC).
These are found mainly in Western dietary patterns,
characterized by high total fat, meat and sugar intake, and low
fiber intake. Such dietary patterns are associated with high
CRC incidence (1). However, it is unclear whether a possible
independent effect of trans fatty acids on CRC risk exists. In
two studies in rats, dietary trans fatty acids did not enhance
dimethylhydrazine-induced colorectal carcinogenesis (2, 3).
Partially-hydrogenated fish oil (PHFO) was a major
component in margarine and shortenings in bakery products
in Norway until the late 1990s, and was one of the major
sources of dietary trans fatty acids in Norway during the past
decades. The composition of trans fatty acids differs between
PHFO and partially-hydrogenated vegetable oil (PHVO).
While PHVO mainly contains the monounsaturated elaidic
acid (18:1trans), PHFO additionally contains several long-
chain mono- and polyunsaturated trans fatty acids (18-22
carboatoms). Dietary raw fish oil has been shown to suppress
intestinal polyp formation and growth in multiple intestinal
neoplasia (Min/+) mice (4). The effect of dietary
hydrogenated fish oils on the formation and growth of
intestinal tumors has been poorly investigated. However, one
recent human prospective study found no association between
intake of PHFO and the risk of colonic or rectal cancer (5).
Neither how dietary fully-hydrogenated fish oil (FHFO), in
which all polyunsaturated fatty acids (PUFA) have been
transformed into long-chained saturated fatty acids (SFA),
might affect intestinal carcinogenesis, is known. However, it
has been shown that dietary FHFO in rats has a low
absorption rate, resulting in reduced weight gain (6). Multiple
intestinal neoplasia (C57BL/6J Min/+) mice (Min/+ mice) are,
similarly to humans with familial adenomatous polyposis
(FAP) syndrome, heterozygous for a mutation in the tumor
suppressor gene (Adenomatous polyposis coli) (Apc). This
results in the development of numerous neoplastic lesions in
the intestines. While human patients with FAP mainly
develop the lesions in the colon, Min/+ mice mainly develop
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lesions in the small intestine (7). Since the initial molecular
pathogenesis with loss of APC function is similar in sporadic
colonic carcinogenesis in humans, the Min/+ mouse provides
a model for colonic carcinogenesis (8).
The aim of this experiment was to investigate the effect of
dietary fish oil hydrogenated to different degrees, on the
number and size of intestinal tumors in Min/+ mice using
raw fish oil as a reference.
Materials and Methods 
C57BL/6J-Min/+ male mice and C57BL/6J-+/+ wild-type (genetic
normal, wt) female mice were purchased from The Jackson
Laboratory (Bar Harbor, ME, USA). All mice were housed at the
animal facility at the Norwegian Institute of Public Health for
approximately 10 days before the study. The mice were kept in
plastic cages with woodchip in the bottom, in a room with a 12-h
light/dark cycle, controlled humidity (55±5%) and temperature (20-
24˚C). During breeding, the mice were given SDS RM3 feed
(Special Diets Services, Witham, Essex, UK) and water ad libitum.
Diets and experimental design. All experimental diets consisted of basic
AIN 76 diet without oil (Research Diets, New Brunswick, NJ, USA;
50% sucrose, 20% casein, 15% corn starch, 5% fiber, 3.5% AIN
mineral mixture, 1% AIN vitamin mixture, 0.3% DL-methionine and
0.2% choline bitartrate), to which experimental fat and corn oil were
added (AIN 76 diet/experimental fat/corn oil in 88/11/1 weight %,
respectively). Corn oil was added to avoid lack of essential fatty acids
(9). The four experimental fats were raw fish oil (FO), low-
hydrogenated fish oil (LHFO), high-hydrogenated fish oil (HHFO) or
fully-hydrogenated fish oil (FHFO). Because the aim was to examine
whether an increased degree of hydrogenation of fish oil had any
impact on intestinal carcinogenesis, we used the mice receiving FO as
a reference/control group. Fatty acid compositions of the experimental
fats are given in Table I. The total content of trans fatty acids (both
monounsaturated fatty acids (MUFA) and PUFA) in the experimental
fats were 0% in FO, 54% in LHFO, 38% in HHFO and <1% in FHFO.
All experimental fats were produced from the same raw fish oil
originating from South-American fish and subsequently routinely
analyzed at Denofa AS, Fredrikstad, Norway. The fats were
immediately wrapped in aluminum foil and kept frozen at –30˚C until
the start of the experiment. During the experiment, the experimental
fats were kept in boxes wrapped in aluminum foil at 4˚C, which upon
opening were filled with nitrogen gas to avoid oxidation of fatty acids.
The study design is given in Figure 1. When the pups were born, the
four experimental treatments were randomized by cages. When three
weeks old, the Min/+ and wt pups were identified by an allele-specific
(PCR)-assay, as previously described (10). Wt female mice were
terminated. The first two weeks after birth, the pups were nursed, and
the experimental diets and water were given ad libitum in animal feed
boxes from 3-5 days of age. At approximately two weeks of age, the
animals started to eat the experimental diet. The mice were weighed
weekly from 32 until 60 days old. At nine weeks of age, the animals
were terminated by cervical dislocation. The small intestine and the
colon were removed separately and rinsed in ice-cold phosphate-
buffered saline (PBS) and the small intestine was divided into proximal,
middle and distal parts. Before being longitudinally incised, the
intestines were fixed flat between wet PBS filter papers for a minimum
of 24 h in 10% neutral buffered formalin. The intestines were stained in
0.2% methylene blue (George T. Gurr Ltd., London, UK) and kept in
10% neutral buffered formalin for a minimum of 24 h before the
number, diameter (mm) and location of lesions (cm distally from the
ventricle) were examined and scored using an inversed light microscope
(Nikon TMS-F, Melville, NY, USA). Tumor size (mm2) was calculated
considering the lesion as a circle, using the formula of circle area:
Area=π × (diameter/2)2, where π=3.14. The small intestines were
examined from the duodenum to the ileum, while the colon was
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Table I. Fatty acid composition of the four experimental fats.
Experimental fat
FO LHFO HHFO FHFO
Fatty acid (%) (%) (%) (%)
14:0 8.3 8.7 8.8 7.7
15:0 0.6 0.6 0.6 0.5
16:0 21.7 21.4 25.6 36.4
17:0 0.5 0.7 0.5 0.6
18:0 4.2 4.8 9.5 22.7
19:0 0.3 0.1 0.2
20:0 0.2 0.5 3.4 17.7
22:0 0.3 1.8 11.7
24:0 0.2 0.8
Sum saturated fatty acids 35.8 37.0 50.5 98.3
14:1, n5 0.2 0.2 0.2 0.1
16:1, n7 10.5 11.8 6.8 0.1
17:1 1.5 0.2
18:1, n7+n9 13.6 17.3 11.1 0.1





Sum monounsaturated fatty acids 29.6 29.5 18.1 0.5
C16:2, n6 1.3 0.1
C18:2, n6 1.6 0.2 0.1
C18:3, n3 0.8
C16:4, n3 0.7 0.1
C18:4, n1 0.2
C18:4, n3 1.7










Sum polyunsaturated fatty acids 29.5 27.1 26.7 0
Sum trans fatty acids 0 54.0 38.0 0
Other 2.0 6.2 4.5 1.2
Total 100 100 100 100
FO: Fish oil; LHFO: low-hydrogenated fish oil; HHFO: high-
hydrogenated fish oil and FHFO: fully-hydrogenated fish oil. a,bAll fatty
acids with this chain length are included.
examined from the proximal part to the anus. The animal experiment
was approved by the Norwegian Animal Research Authority.
Statistical analysis. Data are presented as medians (25th, 75th
quartiles). We analyzed differences in final body weight, number of
tumors and tumor area among Min/+ mice in different intervention
groups by independent samples median test, the FO group serving
as the control group. We assessed body weight development in
different types of mice and dietary intervention groups by fitting a
growth model (the SAS MIXED procedure) with random intercepts
for mice and fixed time, gender and intervention effects. p-Values
<0.05 were considered as being statistically significant. We
conducted the statistical analysis using the software SAS 9.2 (SAS
Institute, Inc., Cary, NC, USA) and SPSS 16.0 for Windows (SPSS
Inc., Chicago, IL, USA).
Results
A total of 86 mice were used in this experiment; 65 were
Min mice (34 females and 31 males) and 21 wt mice (males)
(Table II).
Effect of dietary intervention on the number of intestinal
tumors. The total number of tumors in the small intestine in
Min/+ mice was 3,220, with a median of 45 tumors per
mouse. There was no difference in the median number of
intestinal tumors between the dietary intervention groups
(Table II). In comparison with the reference group (FO), the
median tumor number did not differ in the three other dietary
groups (data not shown). We did not observe any sex
differences in the association between dietary intervention
and tumor number. In the colon, a total number of 30 tumors
were developed, with no significant differences between the
dietary intervention groups (data not shown). The wt mice
did not develop any intestinal tumors.
Effect of dietary intervention on intestinal tumor size and
total tumor load. The mean tumor size was 0.39 mm2. The
median tumor load was 17.46 mm2. There was no difference
in the mean tumor size of each animal or tumor load between
the dietary intervention groups (Table II). The mean tumor
size was significantly lower in the HHFO group when
compared with the control group (0.43 vs. 0.34 mm2,
respectively, p=0.009) (Figure 2). When stratified for gender,
this difference was significant only in males. The tumor size
and tumor load in the other three dietary groups did not differ
from that of the control group (Figures 2 and 3). No gender
differences were found in the association between other
dietary intervention groups and tumor size or tumor load.
Final body weight. Overall, Min/+ mice males had a lower
final body weight than did wt mice (median final weight 21.0
vs. 25.1 g, respectively, p<0.001). Within the group of Min/+
mice, males had a significantly higher final weight than did
females (median final weight 23.9 vs. 19.3 g, respectively,
p<0.001) (data not shown).
Effect of dietary intervention on body weight. There was no
statistically significant difference in the final median weight
between the dietary intervention groups in Min/+ mice (Table
II). Among Min/+ males, there was a significant difference
in final median body weight among the four dietary groups
(p=0.01); the final median weight was lower in the FHFO
group when compared to the control FO group (25.9 vs. 23 g,
p=0.041). In Min/+ females, a significant difference in the
final median body weight among the four dietary groups
(p=0.012) was also found; the final weight was significantly
higher in the LHFO group compared with the control group
(21.3 vs. 18.9 g, respectively, p=0.015) (data not shown).
Weight gain was almost linear at the beginning of the
study period and plateaued later (second-order time variable
was significantly different from zero). Weight gain was
significantly faster for male Min/+ mice as compared with
female mice (p<0.001 for interaction between time of
measurement and gender) (Figure 4, Table III). The Min/+
mice dietary intervention groups HHFO and FHFO had
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Figure 1. Study design. Min/+ mice and their litter mates were treated in four different treatment groups: FO (raw fish oil), LHFO (low hydrogenated
fish oil), HHFO (high hydrogenated fish oil) and FHFO (fully hydrogenated fish oil). The experimental diets were placed in the cages when the
pups were 3-5 days old. The mother nursed the pups until they were genotyped at three weeks of age. From approximately two weeks of age, the pups
started eating the experimental diet until sacrifice at nine weeks of age.
significantly lower weight gains than did the control group
(p=0.008 and p=0.043, respectively), while no significant
difference was observed between the FO and LHFO groups
(Table III). There was a significant gender difference in the
effect of dietary intervention on weight gain (a statistically
significant interaction between genders in HHFO vs. FO,
p=0.017, data not shown). The weight gain was significantly
lower in Min/+ than wt males (p=0.001) (Table III).
However, timing of the weight gain did not differ between
wt and Min mice as no significant interaction between the
type of mouse and time was found. When comparing Min/+
and wt males, we found no significant differences in the
effect of dietary intervention on weight gain (data not
shown).
Correlation between the final body weight, tumor number, size
and load. There was no statistically significant correlation
between final body weight and the number of tumors
(Pearson’s r=–0.156, p=0.214). However, there was a
statistically significant positive correlation between final body
weight and mean tumor size (Pearson’s r=0.313, p=0.011).
There was no difference in the number of tumors or the mean
size between the control group and any of the intervention
groups, when adjusted for starting or final body weight.
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Figure 2. Mean (±standard deviation) tumor size in the small intestine in
male and female Min/+ mice in the four dietary intervention groups (FO;
fish oil, LHFO; low-hydrogenated fish oil, HHFO; high-hydrogenated fish
oil and FHFO; fully-hydrogenated fish oil). *Significantly different from
the reference group for both sexes combined, p=0.009.
Figure 3. Tumour load (mean tumor size × number of tumours) with
standard deviation in small intestine in male and female Min/+ mice in
the four dietary intervention groups (FO: fish oil; LHFO: low-
hydrogenated fish oil; HHFO: high-hydrogenated fish oil; and FHFO:
fully-hydrogenated fish oil).
Table II. Min/+ mouse characteristics. 
FO LHFO HHFO FHFO p-Valuea
wt mice
N 5 6 5 5
Final body weight, day 60 
Median (25th, 75th)b 27.0 (24.9; 27.9) 23.6 (23.0; 25.5) 27.1 (25.6; 27.9) 24.4 (24.1; 24.8) 0.002
Min mice
N 17 15 21 12
Final body weight, day 60 
Median (25th, 75th) 23.9 (18.9; 25.9) 21.6 (20.9; 24.7) 20.4 (19.0; 22.1) 20.6 (18.0; 23.2) 0.113
Number of tumors
Total 822 711 1073 614
Median (25th, 75th) 49.0 (36.5; 52.5) 50.0 (27.0; 58.0) 42.0 (31.5; 66.0) 41.5 (30.5; 75.5) 0.451
Mean tumor size (mm2)
Median (25th, 75th) 0.43 (0.36; 0.51) 0.38 (0.26; 0.45) 0.34 (0.29; 0.41) 0.40 (0.29; 0.47) 0.068
Total tumor load (mm2)c
Median (25th, 75th) 21.9 (16.6; 24.9) 16.2 (11.4; 21.7) 14.5 (10.1; 24.4) 17.0 (10.9; 29.3) 0.174
FO: Fish oil; LHFO: low hydrogenated fish oil; HHFO: high hydrogenated fish oil and FHFO: fully hydrogenated fish oil; wt: wild-type.
aindependent-samples median test. bfirst and third quartiles, all such numbers in parentheses. cnumber of tumors × mean tumor area.
Discussion
The incidence of colorectal cancer has, during past decades,
increased more rapidly in Norway than in any other Nordic
country (11), in parallel with the increase in margarine
consumption (12), which was the main dietary source of
PHFO and trans fats in Norway from the 1930s until 1998.
Considering the high consumption of margarine during the
past decades, PHFO is a dietary factor that makes the
standard Norwegian diet different from that of other Nordic
countries, and therefore it is of interest to investigate its effect
on colorectal carcinogenesis. In this experimental study on
Min/+ and wt mice, we showed that dietary hydrogenated fish
oil did not affect spontaneous colon carcinogenesis differently
from FO. However; hydrogenation of the fish oil had a
negative effect on weight gain. The negative effect on weight
gain in Min/+ mice was observed only for HHFO and FHFO,
and not for the LHFO group. Some gender differences in the
effect of different fat types on body weight was found in
Min/+ mice, indicating that hydrogenated fish oil might have
a negative effect on weight gain only in males. Increased
body weight was associated with increased mean tumor size.
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Figure 4. Body weight of male (M) and female (F) Min/+ mice and male wild-type (wt) mice by dietary intervention group (FO: fish oil; LHFO: low-
hydrogenated fish oil; HHFO: high-hydrogenated fish oil and FHFO: fully-hydrogenated fish oil).
Table III. Weight development in Min/+ mice and wild-type (wt) mice.
Min/+ mice Male Min/+ and wt mice
Coefficient (95% CI) p-Value Coefficient (95% CI) p-Value
Intercepta 12.90 (11.86; 13.94) <0.001 14.12 (13.14; 15.10) <0.001
Time, days 3.22 (2.97; 3.47) <0.001 4.48 (4.21; 4.75) <0.001
Time × Time –0.38 (–0.42; –0.33) <0.001 –0.45 (–0.50; –0.40) <0.001
Genderb
Male –0.16 (–1.13; 0.81) 0.746 NA
Micec
Min/+ NA –2.12 (–3.34; –0.90) 0.001
Time × Gender 0.96 (0.82; 1.09) <0.001
Intervention
FO – ref
LHFO 1.13 (–0.15; 2.41) 0.085
HHFO –1.60 (–2.78; –0.43) 0.008
FHFO –1.40 (–2.76; –0.05) 0.043
aRepresents initial average weight of mice. bReference, Female Min/+ mice. cReference, wt mice. FO: Fish oil; LHFO: low-hydrogenated fish oil;
HHFO: high-hydrogenated fish oil; FHFO: fully-hydrogenated fish oil.
Our study is, to the best of our knowledge, the first of its kind
to investigate the effect of hydrogenation of fish oil on
intestinal carcinogenesis in a Min/+ mouse model. Only one
earlier study has investigated the effect of hydrogenated fish
oil on carcinogenesis in rats, concluding, in agreement with
the present study, that hydrogenated fish oil had no effect on
carcinogenesis (13). Results from rat experiments on the
effect of dietary, partially-hydrogenated vegetable oils rich in
trans fats on colorectal carcinogenesis are also in agreement
with these results (2, 3, 14, 15). The reference (control) fat in
the present study was raw fish oil, which has been found to
reduce intestinal carcinogenesis in the Min mouse (4).
Therefore, a considerably higher tumor load, as a result of
hydrogenated fish oil treatment would have been expected if
hydrogenated fish oil had a truly negative effect on colon
carcinogenesis. 
Epidemiological evidence is similar to our findings and does
not confirm an association between dietary trans fat intake and
CRC risk. A recent prospective study found no increased risk
of cancer in the colon or rectum after intake of PHFO (5) and
two large prospective studies in women found no association
between dietary trans fat and CRC risk (16, 17). Retrospective
studies have found increased risk (18-21), no effect (22, 23) or
increased risk-only in those with low dietary calcium intake
(22), or postmenopausal women not receiving postmenopausal
hormone therapy (18).
Although there is a lack of convincing evidence of any
direct association between dietary trans fat and colorectal
cancer risk, several potential cancer-promoting mechanisms
of trans fatty acids have been suggested. Such mechanisms
are through incorporation of trans fatty acids into cell
membrane phospholipids, resulting in oxidative stress and
inflammation (24). Replacement of dietary SFA and cis-
MUFA with trans fatty acids has been found to change the
lipid profile in the serum and liver of rats (25). A trans fat-
rich diet not only increased inflammatory markers in rats, but
also in their offsprings (26). Human data suggest an
association between trans fatty acid intake and markers of
oxidative stress (27) and inflammation, at least in those who
are overweight (28, 29). Whether this applies to the general
population is, however, uncertain (30).
Restriction of energy intake reduces intestinal tumorigenesis
in Min/+ mice (31). Hydrogenation of fish oil has been shown
to reduce its absorption from the diet (6), and this is possibly
the explanation for the lower weight gain in the HHFO and
FHFO groups, as compared with the FO group. Thus, a
possible negative effect on colonic carcinogenesis of HHFO or
FHFO in the present study might have been compensated by
the effect of the lower energy intake in these groups. The
melting point of trans fatty acids is higher and digestibility
lower, as compared with cis-unsaturated fatty acids of the same
chain length. Therefore, comparison of their biological effects
in a mouse model will in any case be confounded by
differences in energy intake (32). Human studies support a
protective effect of low energy balance; restricted energy intake
in childhood has been associated with decreased risk of
colorectal cancer in adulthood (33). On the other hand, a high
energy intake is associated with increased cancer risk (34, 35).
A weakness of this study is the short intervention time. A
possible effect of hydrogenated fish oil on intestinal
tumorigenesis in Min/+ mice cannot be excluded if it becomes
apparent after a longer exposure time than 60 days, which was
the age at termination in this study. We observed several very
small tumors in female Min/+ mice in the HHFO group (data
not shown). This might indicate a stronger effect of this fat type
on intestinal carcinogenesis, which following a longer
intervention time could have resulted in larger differences
between the groups.
In conclusion, no effect of ingestion of fish oil-
hydrogenated to different degrees, was found on the number
or size of intestinal tumors in Min/+ mice, when using raw fish
oil as a reference oil. However, intake of HHFO and FHFO
resulted in reduced body weight gain when compared with the
group receiving FO, possibly related to reduced bioavailability
of the oil.
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